Guido Giordano
12PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jan 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.Michele Milella, Giulia Orsi, Mariacristina di Marco
|Jun 26, 2024
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.Guido Giordano, Michele Milella, Matteo Landriscina
|Jun 18, 2024
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer?Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno
|May 27, 2023
Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil (CROCC) Alterations.Andrea Remo, Federica Grillo, Luca Mastracci
|May 08, 2023
Pancreatic Enzyme Replacement and Nutritional Support With n ab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer.Guido Giordano, Raffaele Ivan Cincione, Francesca Losavio
|Jun 02, 2021
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro
Pageof 2
Frequent Collaborators
4 joint publications
Massimo Pancione
3 joint publications
Pietro Parcesepe
3 joint publications
Elisa Giommoni
2 joint publications
Sara Lonardi
2 joint publications
Matteo Landriscina
2 joint publications
Giuseppina Bruno
2 joint publications
Michele Milella
2 joint publications
Andrea Remo
1 joint publications
Giulia Scioscia
1 joint publications
Pasquale Tondo
